The dividend needs repeatable earnings, not just a large realization. Reported distributable EPS covers the dividend, but retains a substantial property-sale gain. A changed interest presentation also exaggerates the apparent sequential improvement. Our $9 equity anchor is close to the dated $8.82 price. HOLD, conviction 2/5, with high uncertainty about credit, funding and future distributions.
Authored equity scenarios; USD per common share. Subjective 25%/50%/25% weights, not issuer guidance.
| Scenario | Probability | 12-month value | vs $8.82 | What has to happen | The arithmetic |
|---|---|---|---|---|---|
| Bear | 25% | $6.18 | −30% | Distribution cut and deeper book discount as credit/funding pressure persists. | Dividend base $0.70, return 13%, growth 0%: dividend value $5.3846; 0.60×book=$6.9678; equal-weight blend $6.1762. |
| Base | 50% | $8.83 | +0% | Flat distribution maintained, but uncertain coverage keeps an equity risk discount. | Dividend base $0.92, return 11%, growth 0%: dividend value $8.3636; 0.80×book=$9.2903; equal-weight blend $8.8270. |
| Bull | 25% | $11.19 | +27% | Improved repeatable earnings support a higher distribution and book realization. | Dividend base $0.96, return 10%, growth 1%: dividend value $10.7733; 1.00×book=$11.6129; equal-weight blend $11.1931. |
| 25%×bear +50%×base +25%×bull =$8.7558. The $9 headline is the rounded base blend, not the weighted scenario value. | |||||
| Signpost | Now (Q3 FY2026) | Green if | Red if | Next check |
|---|---|---|---|---|
| Recurring distribution coverage | Reported DE 0.35 includes $30.691m sale gain | Coverage>=1.0× after transparent gain and credit analysis | Coverage<1.0× or another large-gain dependence | November 15, 2026 research check |
| All-funding NII | $23.041m this quarter | Above$25m with stable credit costs | Below$20m or apparent growth from reclassification | February 15, 2027 research check |
| Current filing | September cashflow/segment detail absent | Current 10-Q reconciles reported figures | Missing/revised information prevents reconciliation | November 15, 2026 research check |
| Common book | $11.61/share | Stable or rising after distributions | Below$10.50 with economic credit losses | February 15, 2027 research check |
| Credit detail | June nonaccrual$64.074m | Below$60m with favorable resolution economics | Above$100m or material adverse credit migration | November 15, 2026 research check |
| Distribution | $0.23 quarterly | Maintained and supported by repeatable capacity | Cut or dependence on funding/asset depletion | February 15, 2027 research check |
These dates and thresholds are authored research checkpoints, not confirmed future earnings dates or company guidance. Missing information remains unavailable until verified.
Ladder Capital reported its September-quarter results on October 16, 2026. The exact distribution time remains unconfirmed. The 09:00 Central conference call is a separate event and is not a substitute for the release clock. Our $8.82 reference is the October 15 closing quote, timestamped 20:00:03 UTC. It predates the report. This packet therefore makes no claim about the market's immediate earnings reaction, even though the quote feed also includes a prior-day percentage change.
The central question is whether the apparent earnings recovery supports a durable distribution. Our answer is cautious: HOLD, conviction 2/5, high uncertainty. The rounded $9 equity anchor is close to the dated reference price. The stock trades below reported common book value and offers a high indicated distribution yield, but neither fact establishes a margin of safety. Real-estate sale gains, credit outcomes and funding costs influence what common shareholders can actually receive.
This is an equity analysis of a mortgage lender and property investor. Its financing debt supports earning assets and cannot be treated as incidental industrial-company borrowing. A large securities balance is not automatically excess cash. Restricted cash is not freely distributable cash. We use a dividend model and a discounted book-value scenario, with transparent assumptions, rather than importing a manufacturing-company free-cash-flow multiple.
| Observation | Value | What it establishes |
|---|---|---|
| Reference close | $8.82 | October 15, 2026; not the post-earnings reaction |
| Quarter ended | September 30, 2026 | Q3 FY2026 |
| Actual release | October 16, 2026 | Clock and market session unconfirmed |
| Scheduled call | October 16, 09:00 CDT | Call time is separate from release time |
| Indicated annual dividend | $0.92 | Four times the reported $0.23 quarter; future payment not guaranteed |
| Indicated yield | 10.43% | Uses dated price; not a total-return forecast |
GAAP net income attributable to common shareholders was $65.865 million, or $0.53 per diluted share. Pretax income was $67.336 million. The income statement included a $65.627 million gain on real estate. That gain is economically relevant and properly reported, but its size makes the headline unsuitable as a recurring quarterly run rate. Subtracting the full gain mechanically leaves $1.709 million of pretax income; that calculation is not a complete normalization because other credit, derivative, fee and compensation items also affect the quarter.
Reported after-tax distributable earnings were $43.688 million, or $0.35 per share. Before allowance charge-offs, the company showed $48.167 million of pretax distributable earnings. A $3.500 million charge-off reduced that to $44.667 million; the $0.979 million estimated corporate tax adjustment then produced the after-tax figure. The $0.35 reported amount covers the $0.23 quarterly dividend about 1.52 times. This is a reported comparison, not a promise that the same coverage will recur.
The important qualification is inside the non-GAAP bridge. Distributable earnings retain $30.691 million of the real-estate sale gain. The $34.936 million adjustment removes accumulated depreciation from the GAAP gain; it does not remove the whole sale. Treating distributable earnings as if every disposal benefit had been excluded would give the wrong impression of recurring capacity. Asset sales are a legitimate part of the real-estate business, but timing and realizable prices remain uncertain.
| Current-quarter measure | USD millions / per share | Definition |
|---|---|---|
| Pretax income | 67.336 | Consolidated GAAP |
| GAAP common net income | 65.865 | After tax and noncontrolling attribution |
| Diluted GAAP EPS | $0.53 | Average diluted denominator |
| GAAP property gain | 65.627 | Real-estate realization |
| After-tax distributable earnings | 43.688 | Issuer non-GAAP, includes retained sale gain |
| Distributable EPS | $0.35 | Reported non-GAAP |
| Quarterly dividend | $0.23 | Reported distribution |
| Retained sale gain in DE | 30.691 | Not fully excluded by depreciation adjustment |
Ladder reports Loans, Securities and Real Estate, with Corporate/Other capturing central funding and overhead. The current earnings exhibit does not include the detailed quarterly segment table. The most recent reviewed segment detail is June 30, 2026, and is presented as dated context rather than a September estimate. The nine-quarter appendix preserves that gap. It does not fill a missing quarter with the previous quarter or with provider estimates.
In the June quarter, Loans generated $50.481 million of segment net income, Securities $16.448 million and Real Estate $3.322 million. Corporate/Other recorded a $55.690 million loss. The resulting $14.561 million consolidated total precedes attribution between common shareholders and noncontrolling interests. This is why quoting the sum of the three operating segments without central funding would materially overstate earnings available to common equity.
The balance sheet has shifted as cash was deployed into loans and securities. Gross mortgage loans rose from $2.217 billion at December 2025 to $2.952 billion in September; securities rose from $2.088 billion to $2.276 billion. More earning assets can support income, but their financing and credit performance determine the benefit. At June, multifamily was the largest reported loan collateral category, followed by office. Those dated concentrations identify the questions for the forthcoming filing; they do not establish the September portfolio mix.
| Segment | Q2 2026 net income, $m | Q3 2026 |
|---|---|---|
| Loans | 50.481 | Unavailable in current exhibit |
| Securities | 16.448 | Unavailable in current exhibit |
| Real Estate | 3.322 | Unavailable in current exhibit |
| Corporate/Other | −55.690 | Unavailable in current exhibit |
| Company total | 14.561 | Unavailable in current exhibit |
| Company total is consolidated income before common-shareholder attribution. | ||
The interest presentation requires a separate bridge. September reported net interest income of $28.830 million excludes $5.789 million of real-estate interest presented elsewhere in costs and expenses. The current release also re-presents June net interest income as $28.194 million, whereas the original June release reported $22.587 million. The $5.607 million difference is exactly the real-estate interest moved between presentation categories. June pretax income remains $16.310 million. This is a presentation change, not newly earned profit.
For an explicit all-funding-cost comparison, we subtract September's separately presented real-estate interest from reported net interest income. The resulting $23.041 million compares with original June's $22.587 million, an increase of about 2.0%. It remains about 17.1% below the $27.790 million reported a year earlier. The appendix retains the reported and harmonized series separately. This calculation does not restate the issuer's accounts; it makes the category boundary visible.
Reported distributable EPS over the last four quarters was $0.17, $0.22, $0.24 and $0.35, totaling $0.98 against $0.92 of annualized distributions. That modest numerical cushion depends on the latest quarter's retained sale gain. We do not annualize $0.35 into $1.40 or treat $0.98 as an independently verified forward forecast. A better assessment requires repeated earnings after funding costs, credit charges and the timing of asset realizations.
| June presentation | USD millions | Reconciliation |
|---|---|---|
| Original June NII | 22.587 | Original Q2 earnings exhibit |
| June NII re-presented in Q3 | 28.194 | Real-estate interest moved outside NII |
| Separate real-estate interest | 5.607 | 28.194 − 5.607 = 22.587 |
| June pretax income | 16.310 | Unchanged by the line reclassification |
| September harmonized NII | 23.041 | 28.830 − 5.789 |
| Comparable sequential change | 2.01% | All-funding basis |
| Comparable year-over-year change | −17.09% | All-funding basis |
One useful sensitivity removes the retained $30.691 million sale gain from pretax distributable earnings of $44.667 million, leaving $13.976 million. Holding the disclosed estimated tax amount fixed gives $12.997 million, or roughly $0.104 per diluted share. This is a deliberately limited illustration: tax has not been recomputed, and no claim is made that it is normalized recurring EPS. Its purpose is to show how much of reported coverage depends on this specific realization.
The diluted earnings denominator is approximately 124.885 million shares. Book value uses the actual ending common-share count of 125.992 million instead. The distinction matters because a per-share income measure is an average over the period, while book value is a balance-sheet stock at a point in time. Common shareholders' equity of $1.463 billion is also distinct from total consolidated equity after noncontrolling interests. Mixing these denominators would make an apparently precise valuation internally inconsistent.
The allowance for credit losses was $43.566 million against $2.952 billion of gross mortgage loans, about 1.48%. That ratio is a reported accounting relationship, not an independent estimate of ultimate losses. The latest available nonaccrual detail was $64.074 million at June, compared with $50.707 million in March and $129.679 million at year-end. A falling balance can reflect repayment, sales, foreclosure or other resolution; it does not by itself prove recovered economics. Current September loan-level detail remains unavailable.
| Non-GAAP bridge | USD millions |
|---|---|
| GAAP pretax | 67.336 |
| Noncontrolling share | −0.021 |
| Real-estate adjustment | −26.111 |
| Derivative / loan adjustment | 0.347 |
| Unrealized securities adjustment | 2.889 |
| Impairment adjustment | 0.013 |
| Stock compensation | 3.714 |
| DE before charge-off | 48.167 |
| Allowance charge-off | −3.500 |
| Pretax DE | 44.667 |
| Estimated tax | −0.979 |
| After-tax DE | 43.688 |
| Subtotal rows are not additional adjustments. Property gain retained in DE30.691; net real-estate adjustment combines multiple real-estate adjustments, so it is not identical to the depreciation reversal alone. | |
| Denominator / sensitivity | Value | Interpretation |
|---|---|---|
| Ending common shares | 125.992003m | Book value denominator |
| Average diluted shares | 124.885210m | EPS denominator |
| Common shareholders equity | $1,463.135m | Excludes noncontrolling interest |
| Fixed-tax ex-gain illustration | $0.1041/share | 12.997 /124.885210; not recurring EPS guidance |
Cash and cash equivalents were $41.776 million, with another $21.432 million of restricted cash shown separately. Debt was $4.346 billion, versus $3.510 billion at year-end. Debt divided by common shareholders' equity was approximately 2.97 times. Those facts make access to funding and the behavior of pledged assets important. They do not justify comparing all debt with unrestricted cash as if the entire liability were payable immediately, nor do they justify calling securities cash equivalents.
Annual operating cash flow declined from $180.604 million in 2023 to $133.921 million in 2024 and $87.019 million in 2025. Cash dividends paid to Class A common shareholders were $116.419 million, $117.710 million and $117.413 million, respectively. These annual comparisons are useful context, but operating cash flow is not interchangeable with distributable earnings or dividend capacity in a lending business. Loan classifications and transaction timing can move operating and investing cash between periods.
The reviewed September earnings release does not provide a current cash-flow statement. We therefore do not calculate September operating-cash conversion, free cash flow or cash dividend coverage from estimated inputs. Historical quarter flows are derived from actual year-to-date statements, with fourth quarters calculated as annual totals less nine-month totals. Loan originations and repayments remain identifiable investing flows rather than being relabeled capital expenditure. The forthcoming filing must resolve current cash generation, portfolio turnover and funding use.
| Cash-flow context | 2023 | 2024 | 2025 | Current Q3 2026 |
|---|---|---|---|---|
| Operating cash | 180.604 | 133.921 | 87.019 | Unavailable |
| Investing cash | 793.503 | 932.761 | −1,607.259 | Unavailable |
| Financing cash | −557.766 | −796.586 | 227.042 | Unavailable |
| Loan originations | −68.415 | −195.232 | −1,294.976 | Unavailable |
| Loan repayments | 738.464 | 1,626.554 | 710.985 | Unavailable |
| Cash dividends paid (outflow) | −116.419 | −117.710 | −117.413 | Unavailable |
| Repurchase cash (outflow) | −0.269 | −0.711 | −11.750 | Unavailable |
| USD millions. Current earnings exhibit has no cash-flow statement; annual flows are not current-quarter proxies. | ||||
Current common book value is approximately $11.61 per share. At $8.82, the shares trade at about 0.76 times that book value. Our base book-value scenario applies 0.80 times book, producing about $9.29. The 20% discount is an authored allowance for credit, funding and disclosure uncertainty, not a claim that exactly 20% of assets are impaired. Book value is useful only to the extent that asset values and financing obligations can be realized on acceptable terms.
The second lens discounts an assumed $0.92 annual dividend with no perpetual growth at an 11% required equity return. The value is approximately $8.36. A five-year explicit distribution stream plus a terminal value produces the same answer under these constant assumptions. Maintaining the dividend is a scenario assumption, not a statement that the issuer has guaranteed it. The reported gain-dependent coverage is why the model carries high uncertainty and why the yield is not treated as free income.
Equal weighting of the $9.29 book scenario and $8.36 dividend model gives $8.83, rounded to a $9 headline anchor. These models are not statistically independent: both ultimately depend on credit quality and common equity's earning capacity. The blend makes two assumptions visible rather than manufacturing confidence. Relative to the dated $8.82 price, the base case offers little price upside before distributions, and distributions themselves remain uncertain.
The bear case assumes a $0.70 annual dividend, a 13% required return, zero growth and 0.60 times book. Its blended value is about $6.18. The bull case assumes a $0.96 dividend, 1% growth, a 10% return and book value realized at par, producing about $11.19. These are our scenarios, not management guidance. A sensitivity grid varies the dividend and required return; it shows that a modest change in sustainable distribution can matter more than the apparent discount to book.
At an 11% required return and the $8.82 price, the Gordon dividend equation implies roughly 0.5% perpetual growth from a $0.92 starting dividend. That is a mathematical reverse case, not evidence that such a dividend can be funded. The practical hurdle is distribution durability and asset realization, rather than a spectacular growth forecast. Separately, an additional loss equal to 1% of gross mortgage loans is about $29.5 million, or $0.23 per share before taxes and recoveries. A 1% securities mark is about $22.8 million, or $0.18 per share before hedges. These are independent illustrative shocks, not forecasts.
| Base dividend model | Calculation | USD per share |
|---|---|---|
| Year 1–5 dividend | $0.92 annually; growth 0% | 0.92 each year |
| Required equity return | 11% | Authored assumption |
| PV explicit distributions | Σ0.92/(1.11)^t, t=1…5 | 3.4002 |
| Terminal value at year 5 | 0.92/(0.11−0) | 8.3636 |
| PV terminal | Terminal /1.11^5 | 4.9634 |
| Dividend value | Explicit PV + terminal PV | 8.3636 |
| Book value | 1,463.135m /125.992003m | 11.6129 |
| Book scenario | 0.80 × book | 9.2903 |
| Equal-weight blend | 50% dividend +50% book | 8.8270 |
| Headline anchor | Rounded base blend | 9.00 |
| Reverse case | Input / result |
|---|---|
| Price | $8.82, October 15 close |
| Starting annual dividend | $0.92 |
| Required equity return | 11% |
| Implied perpetual dividend growth | 0.515% |
| Equation | g = (price × required return − dividend)/(price + dividend) |
| Limitation | Does not prove the dividend is sustainable; not a business-growth forecast |
The dated market-data response reports an aggregate price target of $10.25. Its reported high, low and median are identical, which limits the information it provides about dispersion. The grades-consensus response shows 14 Buy, two Hold and one Sell observations. That broad snapshot is different from our low-conviction HOLD and $9 anchor. It is a comparison of provider records and an authored equity model, not a claim that every analyst has reviewed this morning's results.
Individual price-target news rows contain conflicting firm attribution between titles and structured fields. We do not attach those rows to a named brokerage or treat them as clean post-print evidence. Quarterly analyst estimates were unavailable because the provider returned an access limitation. Annual EPS estimates are not a substitute for quarterly consensus, and we make no earnings-beat or miss claim. Fresh dated analyst notes and a reconciled target sample would improve this part of the evidence set.
| Comparison | Wall Street provider snapshot | Charged Alpha |
|---|---|---|
| Rating | 14 Buy /2 Hold /1 Sell observations | HOLD; conviction 2/5 |
| Price target / anchor | $10.25 aggregate; high=low=median | $9 rounded base equity anchor |
| Freshness | Individual report dates not established as post-print | Current release plus dated market inputs |
| Alignment | More optimistic aggregate target | Cautious on recurring distribution coverage |
| Quarterly consensus unavailable. Annual EPS estimates are not quarterly actuals and cannot support a beat/miss claim. | ||
The ordinary property disposal is a topic for analysis, not an automatic reason to exclude the continuing listed issuer. The earnings question is what was realized, what portion appears in distributable earnings and what earning assets remain afterward. A sale can release capital and validate an asset value while simultaneously making quarterly income less repeatable. The $30.691 million retained distributable gain should remain visible in any discussion of management's capital allocation.
A growing loan portfolio and a larger securities book show capital being deployed, but volume alone does not establish value creation. We want the forthcoming filing to identify funding costs, asset yields, collateral and maturities, and to explain any credit resolution. The latest reviewed detailed financing disclosures are dated June, not September. Prior covenant compliance must not be carried forward as an unqualified current assertion. Similarly, historical repurchases and dividends are reported uses of capital, not evidence that future distributions can be maintained without balance-sheet trade-offs.
| Capital-allocation question | Evidence now | Required follow-up |
|---|---|---|
| Realization economics | Property gain is large in GAAP and remains partly in DE | Separate recurring income from asset sales and costs |
| Redeployment | Gross loans $2,951.526m; securities $2,276.280m | Current yields, credit quality and funding cost |
| Distribution durability | Reported $0.35 DE EPS versus $0.23 dividend | Repeated coverage after transparent gain and credit analysis |
| Funding | Debt $4,346.438m; June detailed schedule only | September maturities and collateral terms |
| Internal controls | FY2025 auditor reported effective ICFR | Do not label generic risk factors an actual current weakness |
Credit risk starts with borrower cash flows and collateral realizability, especially where refinancing depends on valuations or occupancy. At June, multifamily and office were important collateral categories. Current-quarter concentration, nonaccrual status and internal risk ratings are not supplied in the earnings exhibit. That is an evidence gap requiring follow-up, not permission to assume either deterioration or improvement. The allowance ratio is not a substitute for loan-level analysis.
Funding risk is separate from credit loss. Securities repurchase arrangements and other financing can create refinancing, collateral and liquidity demands before a loan's ultimate economic outcome is known. The year-end maturity ladder showed substantial obligations in 2026 and 2027; the June ladder changed as the balance sheet evolved. Neither schedule is labeled current September data. A large asset base and positive book value do not eliminate timing mismatches between funding and asset cash flows.
The strongest counterargument to our cautious stance is that successful realizations and deployment could improve sustainable earnings while the shares already price in substantial skepticism. The discount to book could narrow and the current dividend could persist. We would change the view if repeated earnings after funding and credit costs cover distributions without dependence on large realizations, and if updated asset-level disclosures support book value. Conversely, a dividend reduction, worsening credit marks or expensive refinancing would weaken both valuation lenses at once.
| Illustrative shock | USD millions | USD per share | Limits |
|---|---|---|---|
| 1% additional gross-loan loss | 29.515 | 0.234 | Before tax/recoveries; not a forecast |
| 1% securities mark | 22.763 | 0.181 | Before hedges/tax; independent scenario |
| Risk | Authored likelihood | Potential impact | Observable test |
|---|---|---|---|
| Gain-dependent coverage | High | High: dividend-model value falls if distributions shrink | DE bridge and repeatable coverage after realizations |
| Credit realization | Medium | High: losses reduce book value and income | Current nonaccruals, risk ratings and recovery proceeds |
| Refinancing and collateral | Medium | High: funding costs or liquidity pressure | Updated maturities, collateral requirements and unrestricted cash |
| Incomplete current detail | Certain at review | Medium: narrower conviction and larger error range | Current quarterly filing and full supplement |
| Valuation compression | Medium | Medium to high: discount to book can persist | Required equity return and sustainable distribution |
| Qualitative likelihoods are analyst judgments, not statistical probabilities or measured default rates. | |||
The next concrete research event is the current-quarter filing and any complete issuer supplement. It should provide September cash flows, segment results, loan risk and financing detail. Our November 15 research checkpoint is an authored follow-up date, not a confirmed earnings announcement. The scheduled earnings call can clarify management's interpretation, but a call time is neither the release time nor proof that missing financial tables are already available.
We will track harmonized net interest income after all funding categories, reported distributable earnings with the retained sale gain separately identified, distribution coverage, common book value and current nonaccrual exposure. Each test must use the same definition from period to period. Apparent improvement caused by moving real-estate interest to another line would not satisfy the income test. Lower nonaccrual balances without the economics of their resolution would not by themselves satisfy the credit test.
The decision remains HOLD with high uncertainty. The base anchor is near the dated price, and a high indicated yield does not compensate automatically for uncertain durability. A lower price could create a better prospective return only if the credit and funding thesis remains intact. A higher price supported by stronger repeatable earnings could also warrant a revised model. The signposts are intended to make those changes testable rather than turn today's rating into a permanent label.
| Disclosure gap | Why it matters | Current treatment |
|---|---|---|
| September cash-flow statement | Cash generation and capital recycling | Unavailable; no synthetic current cash flow |
| September segment table | Contribution after central funding | June dated context; Q3 unavailable |
| September nonaccrual and risk ratings | Borrower/collateral performance | No inference from older balances |
| Current debt maturity/collateral schedule | Liquidity timing and refinancing | June schedule explicitly dated |
| Quarterly analyst consensus | Any beat/miss comparison | Unavailable; no substituted annual estimates |
The appendix retains nine quarterly reported earnings and balance-sheet observations, the distinct harmonized interest series, eight available quarters of derived cash flow and segment detail, three annual statements and dated credit information. A missing current filing produces an unavailable cell, not zero. Fourth-quarter flow derivations subtract nine-month totals from annual totals; balance-sheet stocks are never subtracted. Segment income reconciles before common-shareholder attribution.
Financial source tables are primarily in thousands of U.S. dollars. The analytical charts convert financial amounts to millions, while per-share values remain ordinary dollars. Ending common shares, diluted earnings shares and provider market-cap share counts have different uses and are not silently substituted. Source documents, table indices, raw cells and file hashes are retained locally. Dated provider market and analyst records are distinct from SEC financial statements and from our model assumptions.
Distributable earnings are a non-GAAP measure defined by the issuer and are not interchangeable with operating cash flow. The gain-removal illustration is not a tax-recomputed recurring forecast. The dividend model assumes a distribution stream; the book model assumes a realization discount. Neither is management guidance. These limitations are central to the conclusion and remain part of the packet, presentation and publication metadata.
| Period | Interest income | Reported NII | All-funding NII | Common NI | Property gain | DE after tax | DE EPS | Dividend |
|---|---|---|---|---|---|---|---|---|
| Q3 2024 | 96.092 | 38.416 | 38.416 | 27.913 | 0.315 | 37.528 | 0.30 | 0.23 |
| Q4 2024 | 78.102 | 27.212 | 27.212 | 31.384 | 12.419 | 34.061 | 0.27 | 0.23 |
| Q1 2025 | 64.326 | 20.329 | 20.329 | 11.775 | 3.807 | 25.246 | 0.20 | 0.23 |
| Q2 2025 | 62.735 | 21.530 | 21.530 | 17.328 | 0.000 | 28.935 | 0.23 | 0.23 |
| Q3 2025 | 71.768 | 27.790 | 27.790 | 19.189 | 0.000 | 31.184 | 0.25 | 0.23 |
| Q4 2025 | 68.065 | 22.328 | 22.328 | 15.890 | 0.000 | 20.966 | 0.17 | 0.23 |
| Q1 2026 | 74.221 | 23.017 | 23.017 | 2.605 | 0.000 | 27.327 | 0.22 | 0.23 |
| Q2 2026 | 78.204 | 22.587 | 22.587 | 14.588 | 0.000 | 29.820 | 0.24 | 0.23 |
| Q3 2026 | 80.446 | 28.830 | 23.041 | 65.865 | 65.627 | 43.688 | 0.35 | 0.23 |
| USD millions except EPS/dividend. Reported original-quarter series; the current release re-presents June NII separately as explained above. | ||||||||
| Period | Cash | Restricted cash | Gross loans | Allowance (contra) | Securities | Debt | Common equity |
|---|---|---|---|---|---|---|---|
| Q3 2024 | 1,607.204 | 12.301 | 2,039.545 | −52.276 | 852.783 | 3,585.332 | 1,532.619 |
| Q4 2024 | 1,323.481 | 12.608 | 1,591.322 | −52.323 | 1,080.839 | 3,135.617 | 1,535.030 |
| Q1 2025 | 479.770 | 13.731 | 1,665.243 | −52.208 | 1,476.380 | 2,769.754 | 1,516.668 |
| Q2 2025 | 134.939 | 13.388 | 1,593.710 | −52.166 | 1,966.471 | 2,783.166 | 1,502.616 |
| Q3 2025 | 49.434 | 13.476 | 1,920.588 | −52.135 | 1,940.547 | 2,997.232 | 1,495.979 |
| Q4 2025 | 37.953 | 14.888 | 2,217.375 | −47.137 | 2,088.285 | 3,510.402 | 1,483.926 |
| Q1 2026 | 33.057 | 18.517 | 2,606.374 | −47.109 | 2,073.679 | 4,027.581 | 1,447.106 |
| Q2 2026 | 37.586 | 16.793 | 2,790.138 | −47.095 | 1,872.439 | 4,004.904 | 1,429.329 |
| Q3 2026 | 41.776 | 21.432 | 2,951.526 | −43.566 | 2,276.280 | 4,346.438 | 1,463.135 |
| USD millions, period-end stocks. These are not quarterly cash movements. | |||||||
| Period | Operating CF | Investing CF | Financing CF | Dividends paid | Loan origins | Loan repayments |
|---|---|---|---|---|---|---|
| Q3 2024 | 169.011 | 146.950 | 175.772 | −28.914 | −2.227 | 511.342 |
| Q4 2024 | −60.121 | 199.091 | −492.145 | −28.897 | −123.422 | 503.864 |
| Q1 2025 | −28.727 | −373.783 | −410.202 | −30.739 | −253.048 | 264.008 |
| Q2 2025 | 44.045 | −405.574 | −23.471 | −29.003 | −159.550 | 210.186 |
| Q3 2025 | 26.338 | −291.410 | 179.655 | −28.844 | −476.105 | 129.864 |
| Q4 2025 | 45.363 | −536.492 | 481.060 | −28.827 | −406.273 | 106.927 |
| Q1 2026 | −7.989 | −450.872 | 457.594 | −30.529 | −555.318 | 91.140 |
| Q2 2026 | 39.270 | 24.164 | −60.629 | −28.759 | −478.957 | 286.671 |
| Q3 2026 | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| USD millions; Q4=annual less nine months. Current Q3 cash flow unavailable. Outflows retain negative signs. | ||||||
| Period | Loans | Securities | Real Estate | Corporate/Other | Company total |
|---|---|---|---|---|---|
| Q3 2024 | 45.720 | 11.695 | −1.291 | −28.562 | 27.562 |
| Q4 2024 | 36.288 | 14.599 | 10.064 | −29.620 | 31.331 |
| Q1 2025 | 29.283 | 20.255 | 2.205 | −40.188 | 11.555 |
| Q2 2025 | 38.210 | 24.361 | 0.788 | −46.251 | 17.108 |
| Q3 2025 | 42.461 | 26.152 | 0.308 | −49.751 | 19.170 |
| Q4 2025 | 40.654 | 23.191 | 0.763 | −48.748 | 15.861 |
| Q1 2026 | 48.326 | 15.892 | 1.437 | −63.052 | 2.603 |
| Q2 2026 | 50.481 | 16.448 | 3.322 | −55.690 | 14.561 |
| Q3 2026 | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| USD millions of segment income before common attribution. Q4 flows derived; current Q3 unavailable. Historical net interest segment totals can differ slightly from original release presentations; no forced plug. | |||||
| Original annual income statement | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Interest income | 407,284 | 358,625 | 266,894 |
| Interest expense | 245,097 | 221,537 | 174,917 |
| Net interest income (expense) | 162,187 | 137,088 | 91,977 |
| Provision for (release of) loan loss reserves, net | 25,096 | 13,933 | −157 |
| Real estate operating income | 96,950 | 98,681 | 99,308 |
| Gain (loss) on real estate, net | 8,808 | 25,277 | 3,807 |
| Compensation and employee benefits | 63,618 | 60,671 | 52,735 |
| Income (loss) before taxes | 104,745 | 110,895 | 67,188 |
| Net income (loss) | 100,501 | 107,447 | 63,695 |
| USD thousands. First annual column from each original 10-K; unavailable exact labels remain explicit. Full original statements, including all cash-flow parts, retained in the source dataset. | |||
| Original annual balance sheet | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Cash and cash equivalents | 1,015,678 | 1,323,481 | 37,953 |
| Restricted cash | 15,450 | 12,608 | 14,888 |
| Mortgage loans receivable | 3,155,089 | 1,591,322 | 2,217,375 |
| Allowance for credit losses | −43,165 | −52,323 | −47,137 |
| Mortgage loan receivables held for sale | 26,868 | 26,898 | 27,986 |
| Securities | 485,533 | 1,080,839 | 2,088,285 |
| Real estate and related lease intangibles, net | 726,442 | 670,803 | 703,537 |
| Total assets | 5,512,677 | 4,845,073 | 5,152,550 |
| Debt obligations, net | 3,783,946 | 3,135,617 | 3,510,402 |
| Total liabilities | 3,980,479 | 3,312,134 | 3,671,193 |
| Total equity | 1,532,198 | 1,532,939 | 1,481,357 |
| USD thousands. First annual column from each original 10-K; unavailable exact labels remain explicit. Full original statements, including all cash-flow parts, retained in the source dataset. | |||
| Original annual cash flow statement parts | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Net income (loss) | 100,501 | 107,447 | 63,695 |
| Depreciation and amortization | 29,914 | 32,327 | 31,995 |
| Net cash provided by (used in) operating activities | 180,604 | 133,921 | 87,019 |
| Net cash provided by (used in) investing activities | 793,503 | 932,761 | −1,607,259 |
| Net cash provided by (used in) financing activities | −557,766 | −796,586 | 227,042 |
| Cash dividends paid to Class A common shareholders | −116,419 | −117,710 | −117,413 |
| USD thousands. First annual column from each original 10-K; unavailable exact labels remain explicit. Full original statements, including all cash-flow parts, retained in the source dataset. | |||
| Period | Nonaccrual loans, $m |
|---|---|
| Q3 2024 | 60.847 |
| Q4 2024 | 76.875 |
| Q1 2025 | 116.137 |
| Q2 2025 | 162.264 |
| Q3 2025 | 122.920 |
| Q4 2025 | 129.679 |
| Q1 2026 | 50.707 |
| Q2 2026 | 64.074 |
| Q3 2026 | Unavailable |
| Amortized cost basis. Latest current-quarter detail unavailable. | |
| Debt maturity as of June 30, 2026 | USD millions |
|---|---|
| Remainder 2026 | 841.613 |
| 2027 | 705.165 |
| 2028 | 24.517 |
| 2029 | 871.694 |
| 2030 | 933.546 |
| Thereafter | 642.640 |
| Gross schedule | 4,019.175 |
| Net debt carrying value | 4,004.904 |
| Dated schedule; not September maturity disclosure. Gross less issuance costs/discounts differs from net carrying debt. | |
| Source / scope | Primary reference | Treatment |
|---|---|---|
| Q3 2024 earnings exhibit | SEC 0001577670-24-000036 | Original release; USD thousands and stated per-share values |
| Q4 2024 earnings exhibit | SEC 0001577670-25-000007 | Original release; USD thousands and stated per-share values |
| Q1 2025 earnings exhibit | SEC 0001577670-25-000021 | Original release; USD thousands and stated per-share values |
| Q2 2025 earnings exhibit | SEC 0001577670-25-000027 | Original release; USD thousands and stated per-share values |
| Q3 2025 earnings exhibit | SEC 0001577670-25-000035 | Original release; USD thousands and stated per-share values |
| Q4 2025 earnings exhibit | SEC 0001577670-26-000005 | Original release; USD thousands and stated per-share values |
| Q1 2026 earnings exhibit | SEC 0001577670-26-000022 | Original release; USD thousands and stated per-share values |
| Q2 2026 earnings exhibit | SEC 0001577670-26-000032 | Original release; USD thousands and stated per-share values |
| Q3 2026 earnings exhibit | SEC 0001577670-26-000050 | Original release; USD thousands and stated per-share values |
| FY2023 annual filing | SEC 0001577670-24-000006 | Income, balance sheet, cash flow and accounting notes |
| FY2024 annual filing | SEC 0001577670-25-000010 | Income, balance sheet, cash flow and accounting notes |
| FY2025 annual filing | SEC 0001577670-26-000011 | Income, balance sheet, cash flow and accounting notes |
| June 30, 2026 10-Q | SEC 0001577670-26-000040 | Segment, cash-flow and risk detail; not current September figures |
| March 31, 2026 10-Q | SEC 0001577670-26-000026 | Segment, cash-flow and risk detail; not current September figures |
| Market data | FMP quote, prices, grades and target aggregate | Retrieved October 16; quote timestamp October 15 20:00:03 UTC |
| Estimate gap | Quarterly analyst-estimates request unavailable | HTTP 402 access limitation; no repeated request or quarterly substitute |
| Model | Charged Alpha authored assumptions | Dividend/required return/book multiple and scenario weights are judgment, not issuer guidance |